|
|
Volumn 11, Issue 2, 2012, Pages 91-94
|
|
2011 FDA drug approvals
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABIRATERONE ACETATE;
ANTINEOPLASTIC AGENT;
AZILSARTAN MEDOXOMIL;
BELATACEPT;
BELIMUMAB;
BOCEPREVIR;
BRENTUXIMAB VEDOTIN;
CLOBAZAM;
CRIZOTINIB;
DEFERIPRONE;
FIDAXOMICIN;
GABAPENTIN ENACARBIL;
GADOBUTROL;
ICATIBANT;
INDACATEROL;
IOFLUPANE I 123;
IPILIMUMAB;
LINAGLIPTIN;
ORPHAN DRUG;
RETIGABINE;
RILPIVIRINE;
RIVAROXABAN;
ROFLUMILAST;
SPINOSAD;
TELAPREVIR;
TICAGRELOR;
TRASTUZUMAB;
UNINDEXED DRUG;
VANDETANIB;
VEMURAFENIB;
VILAZODONE;
ANGIONEUROTIC EDEMA;
CASTRATION RESISTANT PROSTATE CANCER;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
DEEP VEIN THROMBOSIS;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
GRAFT REJECTION;
HEPATITIS C;
HODGKIN DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HYPERTENSION;
IRON OVERLOAD;
LARGE CELL LYMPHOMA;
LUNG NON SMALL CELL CANCER;
LYMPHOMA;
MAJOR DEPRESSION;
MELANOMA;
METASTASIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PARKINSONISM;
PEDICULOSIS CAPITIS;
PRIORITY JOURNAL;
RESTLESS LEGS SYNDROME;
REVIEW;
SEIZURE;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THROMBOSIS;
THYROID CANCER;
ANTINEOPLASTIC AGENTS;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
NEOPLASMS;
ORPHAN DRUG PRODUCTION;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84856509534
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3657 Document Type: Review |
|
Times cited : (147)
|
|
References (0)
|
